← back to search

Jennifer K. Plichta

Duke University · US
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, BRCA gene mutations in cancer, and Breast Implant and Reconstruction.
h-index
32
citations
4,083
works
244
NIH funding
primary concept
Medicine
email

Recent publications

Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study
Annals of Oncology 2025cited by 1position: middledoi
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Journal of Clinical Oncology 2024cited by 165position: middledoi
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks
Annals of Surgical Oncology 2024cited by 17position: middledoi
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks
Annals of Surgical Oncology 2024cited by 10position: middledoi
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023
Journal of the National Comprehensive Cancer Network 2023cited by 134position: middledoi
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer
Journal of Clinical Oncology 2023cited by 42position: firstdoi
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
Breast Cancer Research and Treatment 2023cited by 14position: middledoi
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: A National Cancer Database Analysis
Research Square 2023cited by 1position: middledoi
Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast
Journal of Surgical Oncology 2022cited by 18position: middledoi
Management of Male Breast Cancer: ASCO Guideline
Journal of Clinical Oncology 2020cited by 246position: middledoi
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement
American Journal of Transplantation 2020cited by 154position: middledoi
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
American Journal of Transplantation 2020cited by 84position: middledoi
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
Breast Cancer Research and Treatment 2017cited by 192position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Samantha M. Thomas · Duke University4 papers (2022–2023)Yueping Liu · Hebei Medical University2 papers (2023–2023)Mark R. Somerfield · American Society of Clinical Oncology2 papers (2020–2024)Qingyi Wei · Duke University2 papers (2023–2023)Sheng Luo · University of Florida2 papers (2023–2023)Kan Li · Saitama Medical University2 papers (2023–2023) · 2 papers (2023–2023)Li Tang · Tianjin University of Traditional Chinese Medicine2 papers (2023–2023)Yuanyuan Guo · Inner Mongolia Agricultural University2 papers (2023–2023)Fei Ma · Academy of Medical Sciences2 papers (2023–2023)Christine Laronga · Moffitt Cancer Center2 papers (2024–2024)Huiyue Li · Wenzhou Medical University2 papers (2023–2023)Yizi Jin · Shanghai Medical College of Fudan University2 papers (2023–2023)Judy C. Boughey · Mayo Clinic2 papers (2024–2024)Doreen M. Agnese · The Ohio State University1 papers (2024–2024)Shayna L. Showalter · University of Virginia1 papers (2024–2024)Mariana Chávez‐MacGregor · The University of Texas MD Anderson Cancer Center1 papers (2023–2023)Benjamin D. Smith · Edward Via College of Osteopathic Medicine1 papers (2023–2023) · 1 papers (2024–2024)Mark E. Robson · University of Edinburgh1 papers (2024–2024)